SCHEMBL7090330

SCHEMBL7090330

CCCOc1nc2sc(Cl)cc2c(=NC(=O)O)n1CCC

nearest known ligand 0.34

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 1/20 0.34
▸ MAPK1 P28482 1/20 0.30
▸ P2RX3 P56373 1/20 0.30
▸ DHODH Q02127 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7090328 1.00 USP2 (0.34) USP2MAPK1P2RX3DHODH
SCHEMBL7093436 0.92 USP2 (0.34) USP2MAPK1DHODH
SCHEMBL7093437 0.92 USP2 (0.34) USP2MAPK1DHODH
SCHEMBL193613 0.81 USP2 (0.47) USP2MAPK1
SCHEMBL7095466 0.78 USP2 (0.36) USP2MAPK1
SCHEMBL7091201 0.75 AGTR1 (0.39) —
SCHEMBL7091198 0.75 AGTR1 (0.39) —
SCHEMBL7966994 0.75 USP2 (0.41) USP2MAPK1
SCHEMBL7979203 0.74 MAPK1 (0.40) USP2MAPK1
SCHEMBL7838892 0.72 USP2 (0.35) USP2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6617330-B2 For controlling and preventing pests SYNGENTA PARTICIPATIONS AG (CH) 2003-09-09 — — US disclosed
US-20030040521-A1 Novel pyrimidin-4-enamine as fungicide SYNGENTA PARTICIPATIONS AG (CH) 2003-02-27 — — US disclosed
EP-1124830-A1 PYRIMIDIN-4-ENAMINE AS FUNGICIDE Syngenta Participations AG (CH) 2001-08-22 — — EP disclosed
WO-2000031082-A1 PYRIMIDIN-4-ENAMINE AS FUNGICIDE SYNGENTA PARTICIPATIONS AG (CH) 2000-06-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030040521-A1 Novel pyrimidin-4-enamine as fungicide AOC1, CBR3, AOC3 USP2 4110/4885MAPK1 1472/4885P2RX3 1655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback